GlaxoSmithKline
GSK
#289
Rank
C$96.68 B
Marketcap
$46.79
Share price
1.71%
Change (1 day)
-12.50%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $4.72

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $5.02. In 2022 the company made an earnings per share (EPS) of $12.16 an increase over its 2021 EPS that were of $4.29.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.72-61.18%
2022$12.16183.39%
2021$4.29-17.83%
2020$5.2221.82%
2019$4.2923.91%
2018$3.46141.48%
2017$1.4364.6%
2016$0.87-90.64%
2015$9.30178.14%
2014$3.34-48.16%
2013$6.4522.63%
2012$5.26-11.32%
2011$5.93230.25%
2010$1.80-70.98%
2009$6.196.76%
2008$5.80-15.14%
2007$6.837.82%
2006$6.3419.61%
2005$5.3018.56%
2004$4.470.36%
2003$4.4550.39%
2002$2.9631.13%
2001$2.26-25.43%
2000$3.0331.58%
1999$2.301.05%
1998$2.28-0.98%
1997$2.30-10.07%
1996$2.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.85-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.67-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.61-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.36 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.56-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$2.87-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.25-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA